Prostatype Genomics AB financial statements
Prostatype Genomics AB's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | SEK 594K | EODHD |
| Net income | −SEK 44.5M | EODHD |
| Cash and equivalents | SEK 9.07M | EODHD |
| Total debt | SEK 5.3M | EODHD |
Prostatype Genomics AB financials on 6ix · Prostatype Genomics AB on 6ix